** Shares of Laboratory Corporation of America Holdings
LH.N up 1.1% at $248.08
** Brokerage Baird raises PT on LH to $285 from $270; cites
issue related to importation of non-human primates (NHP) from
Cambodia "appears less daunting than first feared"
** NHPs were main animals employed in many pre-clinical
tests
** Brokerage adds that diagnostics volumes are improving and
coming back to normal pre-pandemic levels and growth
** Baird also expects extension of COVID public health
emergency and corresponding reimbursement benefit through
mid-April to help LabCorp's profit
** LH shares lost ~25% in 2022
(Reporting by Raghav Mahobe)
((Raghav.Mahobe@thomsonreuters.com;))